SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat

Article citations


Koukourakis, M.I., Papazoglou, D., Giatromanolaki, A., Bougioukas, G., Maltezos, E. and Sivridis, E. (2004) VEGF Gene Sequence Variation Defines VEGF Gene Expression Status and Angiogenic Activity in Non-Small Cell Lung Cancer. Lung Cancer, 46, 293-298.

has been cited by the following article:

  • TITLE: Association of Polymorphic Variants of VEGF and KDR Genes with Development and Metastasing of Non-Small Cell Lung Cancer

    AUTHORS: А. N. Shchayuk, E. V. Krupnova, M. N. Shapetska, A. P. Mikhalenka, N. V. Chebotareva, A. V. Kilchevsky

    KEYWORDS: Non-Small Cell Lung Cancer, Angiogenesis, Vascular Endothelial Growth Factor, VEGF Gene Polymorphism, KDR Gene Polymorphism

    JOURNAL NAME: Journal of Cancer Therapy, Vol.9 No.9, September 11, 2018

    ABSTRACT: Vascular endothelial growth factor (VEGF) is one of the most important and specific factors affecting angiogenesis in tumor development. VEGFR2 is a receptor encoded by the KDR gene. VEGF and VEGFR2 transmit a signal to intracellular tyrosine kinase cascades. Polymorphic variants of the VEGF and KDR genes significantly influence the expression levels of the endothelial growth factor and its receptor, which leads to a change in the activation of angiogenesis in oncopathological processes. In this study, the relationship between the polymorphic variants rs2010963, rs699947 and rs3025039 of the VEGF gene and rs1870377 and rs2071559 of the KDR gene was analyzed with the development of a specific histological type of non-small cell lung cancer and its clinical and morphological characteristics. It was established that the development of squamous cell carcinoma is associated with -634CC genotype of the VEGF gene and the genotypes containing -2578A allele of the VEGF gene reduce the likelihood of this cancer type development. The development of adenocarcinoma is associated with +936CC VEGF/1719TT KDR and +936CT VEGF/1719TT KDR combinations. In women with non-small cell lung cancer, -634GC genotype of the VEGF gene is associated with a greater degree of the primary lesion spread. Genotype -2578СС of the VEGF gene is associated with a higher degree of the primary tumor spread in the general group of patients and with regional metastases in women. Haplotypes -634G/-2578C/+936C are risky for the occurrence of metastases in regional lymph nodes in women.